Chemoinformaics analysis of GERAINIC-ACID
Molecular Weight | 182.263 | nRot | 4 |
Heavy Atom Molecular Weight | 164.119 | nRig | 3 |
Exact Molecular Weight | 182.131 | nRing | 0 |
Solubility: LogS | -2.798 | nHRing | 0 |
Solubility: LogP | 3.145 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 31.9763 |
nHD | 0 | BPOL | 20.6617 |
QED | 0.379 |
Synth | 2.545 |
Natural Product Likeliness | 2.232 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.633 |
Pgp-sub | 0.014 |
HIA | 0.007 |
CACO-2 | -4.4 |
MDCK | 0.000025 |
BBB | 0.971 |
PPB | 0.90993 |
VDSS | 2.856 |
FU | 0.134911 |
CYP1A2-inh | 0.926 |
CYP1A2-sub | 0.727 |
CYP2c19-inh | 0.88 |
CYP2c19-sub | 0.864 |
CYP2c9-inh | 0.716 |
CYP2c9-sub | 0.74 |
CYP2d6-inh | 0.119 |
CYP2d6-sub | 0.245 |
CYP3a4-inh | 0.15 |
CYP3a4-sub | 0.28 |
CL | 8.027 |
T12 | 0.777 |
hERG | 0.019 |
Ames | 0.003 |
ROA | 0.011 |
SkinSen | 0.947 |
Carcinogencity | 0.074 |
EI | 0.921 |
Respiratory | 0.134 |
NR-Aromatase | 0.016 |
Antiviral | No |
Prediction | 0.827516 |